million consumers in the Cuidados pela Vida
(“Care for Life”) patient assistance program.
new products, already representing
2% of the Company’s Net Revenues.
An EBITDA of
million, an increase of 6.9% over 2016.
Leader in prescription for the
awards received in different scopes.